Bayer warned about aspirin marketing

October 30, 2008 · Print This Article

Federal regulators issued warnings Tuesday to drugmaker Bayer over marketing linked to two aspirin medicines. The Food and Drug Administration said that the Bayer Women’s Low Dose Aspirin + Calcium and Bayer Aspirin With Health Advantage products had been marketed illegally with unproven medical claims. An FDA official said the agency plans to take enforcement action against the company for the violations.

You can read more in the New York Times by clicking HERE.

If you believe you have been injured as a result of taking any pharmaceutical drug, including Byetta, Chantix, Traysol, Digitek, or Celebrex, click HERE.

The law firm of Glassman, Edwards, Wade & Wyatt, and attorneys Tim Edwards and Ed Wallis, are providing free case evaluations about your injuries. Please call (901) 527-4673 and ask to speak to Tim Edwards or Ed Wallis today. You can also email us by clicking HERE.

Comments

Got something to say?